Although the survey responses from the validation process with medical and pharmacy directors indicated that the tool could increase clarity, consistency, and transparency in formulary decision making, the tool did not hold up during real-world pilot testing. Participants in the pilot testing portion of the project indicated that the tool did not capture the dynamic and complex variables involved in the formulary decision making process, and therefore would not be suitable for more sophisticated organizations. Read more here. (Source: PharmaLive, 2013).
You are here: / New Formulary Decision Making Tool Shows Promise in Study; Falls Short in Real World